Published in TB and Outbreaks Week, September 2nd, 2003
As the original developer and manufacturer of the LeadCare, a U.S. Food and Drug Administration (FDA) approved portable blood-lead test, Alderon Biosciences has been chosen to research and develop a broad range of rapid and portable detection systems for the U.S. health and environmental markets.
Alderon Biosciences has received over 32 competitive federal research grants and contracts for the development of various novel detection systems since its founding in 1985. The two new research grants include one for HIV viral load monitoring, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week